Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.964 USD | +9.71% | +43.86% | -31.63% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
End-of-day quotes
Sector Medical Equipment
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
43.75M | - | - | - | |||
12.37B | ||||||
7.96B | ||||||
7.09B | - | - | ||||
5.83B | ||||||
5.35B | - | - |